Evidence map›Paper›PMID 30865436›Full record

ArticleJournal of the American Chemical Society2019

Asymmetric δ-Lactam Synthesis with a Monomeric Streptavidin Artificial Metalloenzyme.

Isra S Hassan, Angeline N Ta, Michael W Danneman, Natthawat Semakul, Matthew Burns, Corey H Basch, Vanessa N Dippon, Brian R McNaughton, Tomislav Rovis

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 128 citations in OpenAlex.

  1. Article
  2. Reprogramming NAD(P)Angewandte Chemie (International ed. in English) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Multifunctional Biocatalysts for Organic Synthesis.Journal of the American Chemical Society · 2024
    Review
  7. An artificial nickel chlorinase based on the biotin-streptavidin technology.Chemical communications (Cambridge, England) · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. An Artificial [FeJournal of the American Chemical Society · 2023
    Article
  12. Article
  13. Tuning through-space interactionsChemical science · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Interrupted Pyridine Hydrogenation: Asymmetric Synthesis of δ-Lactams.Angewandte Chemie (International ed. in English) · 2021
    Article
  19. Article
  20. Directed Evolution of a Cp*RhChembiochem : a European journal of chemical biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Isra S HassanDepartment of Chemistry , Columbia University , New York , New York 10027 , United States.
Angeline N TaDepartment of Chemistry , Colorado State University , Fort Collins , Colorado 80523 , United States.
Michael W DannemanDepartment of Chemistry , Columbia University , New York , New York 10027 , United States.
Natthawat SemakulDepartment of Chemistry , Columbia University , New York , New York 10027 , United States.ORCID 0000-0003-2078-3201
Matthew BurnsDepartment of Chemistry , Columbia University , New York , New York 10027 , United States.
Corey H BaschDepartment of Chemistry , Columbia University , New York , New York 10027 , United States.
Vanessa N DipponDepartment of Chemistry , Columbia University , New York , New York 10027 , United States.
Brian R McNaughtonDepartment of Chemistry , Colorado State University , Fort Collins , Colorado 80523 , United States.ORCID 0000-0001-6452-1065
Tomislav RovisDepartment of Chemistry , Columbia University , New York , New York 10027 , United States.ORCID 0000-0001-6287-8669
Columbia University · USColorado State University · US

Funding

Asymmetric Synthesis of Nitrogen HeterocyclesR01GM080442 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ROVIS, TOMISLAV · 2007 to 2024
$5.5M
Identification of Protein Drug Leads That Address Challenges to Small Molecule CeR01GM107520 · NIGMS · COLORADO STATE UNIVERSITY · PI KENNAN, ALAN J · 2014 to 2018
$1.4M
NIGMS NIH HHS R01 GM080442NIGMS NIH HHS R01 GM107520
6 · The paper itself

Abstract

Reliable design of artificial metalloenzymes (ArMs) to access transformations not observed in nature remains a long-standing and important challenge. We report that a monomeric streptavidin (mSav) Rh(III) ArM permits asymmetric synthesis of α,β-unsaturated-δ-lactams via a tandem C-H activation and [4+2] annulation reaction. These products are readily derivatized to enantioenriched piperidines, the most common N-heterocycle found in FDA approved pharmaceuticals. Desired δ-lactams are achieved in yields as high as 99% and enantiomeric excess of 97% under aqueous conditions at room temperature. Embedding a Rh cyclopentadienyl (Cp*) catalyst in the active site of mSav results in improved stereocontrol and a 7-fold enhancement in reactivity relative to the isolated biotinylated Rh(III) cofactor. In addition, mSav-Rh outperforms its well-established tetrameric forms, displaying 11-33 times more reactivity.

Indexed as

Biomimetic MaterialsChemistry Techniques, SyntheticLactamsMetalloproteinsModels, MolecularProtein ConformationStreptavidinLactamsMetalloproteinsStreptavidin

Identifiers

PMID30865436
PMCPMC6980373
OpenAlexW2922256660

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.